DUANE PATTERSON: Open Payments
NPI 1154054344 · CENTRALIA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$457 in 13 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $546 · 2025 $457
Food & beverage: $457
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $180 |
| E.R. Squibb & Sons, L.L.C. | 2 | $150 |
| ABBVIE INC. | 3 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: COBENFY, ABILIFY ASIMTUFII, VRAYLAR, REXULTI, TRINTELLIX, INGREZZA, Jornay PM, UZEDY.
Industry payments across WA — which companies pay providers there.
